Earnings Review: AstraZeneca Increases Profit Outlook, Reports 17% EPS Growth
November 09, 2023 at 07:12 AM EST
AstraZeneca reported an EPS of $1.73 for Q3 2023 and $5.8 for 9M 2023.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.